The estimated Net Worth of Advisors Llc Orbimed is at least $82.5 Milion dollars as of 14 February 2018. Advisors Orbimed owns over 945,819 units of Guardant Health Inc stock worth over $82,472,103 and over the last 18 years Advisors sold GH stock worth over $0.
Advisors has made over 4 trades of the Guardant Health Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Advisors bought 945,819 units of GH stock worth $6,809,897 on 14 February 2018.
The largest trade Advisors's ever made was buying 945,819 units of Guardant Health Inc stock on 14 February 2018 worth over $6,809,897. On average, Advisors trades about 223,212 units every 98 days since 2007. As of 14 February 2018 Advisors still owns at least 3,316,128 units of Guardant Health Inc stock.
You can see the complete history of Advisors Orbimed stock trades at the bottom of the page.
Advisors's mailing address filed with the SEC is 601 Lexington Ave, New York, NY 10022, USA.
Over the last 6 years, insiders at Guardant Health Inc have traded over $2,653,630,540 worth of Guardant Health Inc stock and bought 2,438,210 units worth $45,173,576 . The most active insiders traders include Bluebird (Cayman) Ltd Softb..., Bluebird (Cayman) Ltd Svf E... a Helmy Eltoukhy. On average, Guardant Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of $2,415,822. The most recent stock trade was executed by Kumud Kalia on 9 September 2024, trading 6,545 units of GH stock currently worth $162,774.
we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.
Guardant Health Inc executives and other stock owners filed with the SEC include: